Ocrelizumab

2 Drugs classified under this active ingredient

Anti-CD20, Monoclonal Antibody. Ocrelizumab 300 mg / 10 ml.
VIAL: 1×10ml. 300 mg IV  infus., follow.  two wks. later by a 2^ND 300 mg IV infus. Subseq. doses: single 600 mg IV infus.  every 6 mnths. See lit.
Tmt. of adult pts. with relaps. or primary progres. forms of multiple sclerosis.
C/I: Hypersens. Active HBV infec. A history of life-threatening infus. reaction to Ocrelizumab.

Anti-CD20, Human Monoclonal Antibody. Ocrelizumab 40 mg/ml.
Vial. 1 X 920 mg for SC inject.
single 23 mL in the abdomen over approx. 10 minutes every 6 months.
For adults with relapsing or primary progress. forms of multiple sclerosis.
C/I:Hypersens. Active HBV infection/ A hist. of life-threatening admin. reaction to ocrelizumab